ENTRY       D09593                      Drug
NAME        Girentuximab (USAN/INN)
FORMULA     C6460H10006N1718O2018S48
EXACT_MASS  145473.9755
MOL_WEIGHT  145563.9894
SEQUENCE    (Heavy chain)
            DVKLVESGGG LVKLGGSLKL SCAASGFTFS NYYMSWVRQT PEKRLELVAA INSDGGITYY
            LDTVKGRFTI SRDNAKNTLY LQMSSLKSED TALFYCARHR SGYFSMDYWG QGTSVTVSSA
            STKGPSVFPL APSSKSTSGG TAALGCLVKD YFPEPVTVSW NSGALTSGVH TFPAVLQSSG
            LYSLSSVVTV PSSSLGTQTY ICNVNHKPSN TKVDKKVEPK SCDKTHTCPP CPAPELLGGP
            SVFLFPPKPK DTLMISRTPE VTCVVVDVSH EDPEVKFNWY VDGVEVHNAK TKPREEQYNS
            TYRVVSVLTV LHQDWLNGKE YKCKVSNKAL PAPIEKTISK AKGQPREPQV YTLPPSRDEL
            TKNQVSLTCL VKGFYPSDIA VEWESNGQPE NNYKTTPPVL DSDGSFFLYS KLTVDKSRWQ
            QGNVFSCSVM HEALHNHYTQ KSLSLSPGK
            (Light chain)
            DIVMTQSQRF MSTTVGDRVS ITCKASQNVV SAVAWYQQKP GQSPKLLIYS ASNRYTGVPD
            RFTGSGSGTD FTLTISNMQS EDLADFFCQQ YSNYPWTFGG GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H146-H202, H263-H323, H369-H427, H228-H'228, H231-H'231, L23-L88, L134-L194, H222-L214)
  TYPE      Peptide
EFFICACY    Antineoplastic, Natural killer cell stimulant
  TYPE      Monoclonal antibody
TARGET      CA9 [HSA:768] [KO:K01672]
BRITE       Target-based classification of drugs [BR:br08310]
             Enzymes
              Lyases (EC4)
               Aldehyde-lyases
                CA9
                 D09593  Girentuximab (USAN/INN)
DBLINKS     CAS: 916138-87-9
            PubChem: 124490333
///
